Abstract
Although the specific etiology of biliary atresia (BA) is unknown, evidence is accumulating that this disease is a dynamic process that begins before birth. The diagnosis and treatment of BA in a term infant was performed in the first 9 days of life with an excellent outcome. Analysis of λ-glutamyl transpeptidase enzyme levels in amniotic fluid provides further insight into the prenatal temporal onset of BA. These findings suggest that BA involves gradual biliary occlusion that may begin weeks before birth.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
